Roche will pay $4.8 billion to acquire gene-therapy pioneer Spark Therapeutics
Monday, May 27, 2019 - 21:07
in Mathematics & Economics
The premium price indicates drug companies' growing interest in joining the gene-therapy field
Updated by artificial intelligence Sat, 3 Jan 2026, 15:40:35 UTC Learn more
- Tell your friends
- Get science news via